Decision Aid Summary

Title Stage IV Non-Small Cell Lung Cancer: First-Line Chemotherapy; Second-Line Chemotherapy; Second- or Third-Line Chemotherapy with Erlotinib; Third-Line and Fourth-Line Chemotherapy: Decision Aid Set.
Audience Medical oncologists treating people diagnosed with stage IV non-small cell lung cancer and people diagnosed with stage IV non-small cell lung cancer and their caregivers, working together.
Options included Chemotherapy.
Erlotinib.
Best supportive care (hospice).
Year of last update or review 2017
Format Web, paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer American Society of Clinical Oncology (ASCO)
Where was it developed? www.asco.org/guidelines, guidelines@asco.org
American Society of Clinical Oncology
US
Health condition Lung Cancer
Type of decision aid Treatment
Language English
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
6 out of 7 criteria to be defined as a patient decision aid
5 out of 9 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2017-04-06.